Literature DB >> 18322380

Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidon.

Yotam Nisemblat1, Haim Belinson, Iftach Dolev, Daniel M Michaelson.   

Abstract

We presently investigated the pathological effects of prolonged inhibition of brain beta-amyloid (Abeta) degradation in vivo. The results obtained revealed that intracerebroventricular injection of the protease inhibitor phosphoramidon into wild-type mice for up to a month elevated the soluble and deposited brain Abeta levels and concomitantly induced the neurodegeneration of distinct hippocampal neurons as well as neuroinflammation. These findings reproduce pathological effects associated with the initial stages of the amyloid cascade and provide a novel model system for studying their underlying mechanisms. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322380     DOI: 10.1159/000113692

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  5 in total

1.  Neprilysin-2 is an important β-amyloid degrading enzyme.

Authors:  Daniel Hafez; Jeffrey Y Huang; Alexis M Huynh; Stephanie Valtierra; Edward Rockenstein; Angela M Bruno; Bao Lu; Luc DesGroseillers; Eliezer Masliah; Robert A Marr
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 2.  Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy.

Authors:  Kevin A Clayton; Alicia A Van Enoo; Tsuneya Ikezu
Journal:  Front Neurosci       Date:  2017-12-12       Impact factor: 4.677

3.  5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease.

Authors:  Christian Klein; Guy Roussel; Susana Brun; Cristina Rusu; Christine Patte-Mensah; Michel Maitre; Ayikoe-Guy Mensah-Nyagan
Journal:  Acta Neuropathol Commun       Date:  2018-12-11       Impact factor: 7.801

Review 4.  Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance.

Authors:  Robert A Marr; Daniel M Hafez
Journal:  Front Aging Neurosci       Date:  2014-08-13       Impact factor: 5.750

Review 5.  Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.

Authors:  J Scott Miners; Jennifer C Palmer; Hannah Tayler; Laura E Palmer; Emma Ashby; Patrick G Kehoe; Seth Love
Journal:  Front Aging Neurosci       Date:  2014-09-11       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.